Black Rock Inc. Blueprint Medicines Corp Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
336Shares Held
62MCall Options Held
987KPut Options Held
578K-
Vanguard Group Inc Valley Forge, PA6.54MShares$545 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$490 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$270 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$205 Million8.22% of portfolio
-
State Street Corp Boston, MA2.38MShares$198 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $4.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...